The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management
Diabetes, obesity & metabolism, 2024-04, Vol.26 Suppl 2, p.46
2024 John Wiley & Sons Ltd. ;EISSN: 1463-1326 ;DOI: 10.1111/dom.15555 ;PMID: 38504134
Digital Resources/Online E-Resources